VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 75 filers reported holding VYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,827 | -1.5% | 23,472 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $96,235 | +133559.7% | 23,472 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $72 | +700.0% | 23,472 | -62.4% | 0.00% | +300.0% |
| Q4 2022 | $9 | -100.0% | 62,500 | -50.0% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | +16.7% | 125,000 | +100.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -41.5% | 62,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $41,000 | -35.9% | 62,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $64,000 | -8.6% | 62,500 | +25.0% | 0.00% | -25.0% |
| Q3 2021 | $70,000 | -47.0% | 50,000 | +33.3% | 0.00% | -42.9% |
| Q2 2021 | $132,000 | -22.8% | 37,500 | +50.0% | 0.01% | -22.2% |
| Q1 2021 | $171,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 2,551,000 | $2,602,000 | 2.01% |
| Perceptive Advisors | 4,356,044 | $4,444,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 217,747 | $222,000 | 0.03% |
| Virtu Financial LLC | 175,278 | $179,000 | 0.02% |
| XTX Topco Ltd | 17,053 | $17,000 | 0.01% |
| SkyOak Wealth, LLC | 27,200 | $28,000 | 0.01% |
| DELTEC ASSET MANAGEMENT LLC | 30,000 | $31,000 | 0.01% |
| Tekla Capital Management LLC | 135,395 | $138,000 | 0.00% |
| STALEY CAPITAL ADVISERS INC | 62,500 | $64,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 47,475 | $48,000 | 0.00% |